(Q47628965)

4 February 2018

title

Effects of nicotine and amphetamine on latent inhibition in human subjects (English)

1 reference

4 February 2018

human subject research project

main subject

0 references

0 references

S. Frangou

7

0 references

author name string

J C Thornton

1

1 reference

4 February 2018

S Dawe

2

1 reference

4 February 2018

C Lee

3

1 reference

4 February 2018

C Capstick

4

1 reference

4 February 2018

P J Corr

5

1 reference

4 February 2018

P Cotter

6

1 reference

4 February 2018

S Frangou

7

1 reference

4 February 2018

N S Gray

8

1 reference

4 February 2018

M A Russell

9

1 reference

4 February 2018

J A Gray

10

1 reference

4 February 2018

J. C. Thornton

1

0 references

S. Dawe

2

0 references

C. Lee

3

0 references

C. Capstick

4

0 references

P. J. Corr

5

0 references

P. Cotter

6

0 references

N. S. Gray

8

0 references

M. A. H. Russell

9

0 references

J. A. Gray

10

0 references

publication date

1 September 1996

1 reference

4 February 2018

June 1996

0 references

published in

Psychopharmacology

1 reference

4 February 2018

volume

127

1 reference

4 February 2018

issue

2

1 reference

4 February 2018

1-2

0 references

page(s)

164-173

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.1007/bf02805990

exact match

0 references

cites work

Differential performance of acute and chronic schizophrenics in a latent inhibition task.

1 reference

12 December 2020

Latent inhibition of conditioned dopamine release in rat nucleus accumbens.

1 reference

12 December 2020

Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET.

1 reference

12 December 2020

Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain

1 reference

12 December 2020

Drowsiness due to chlorpromazine in relation to cigarette smoking. A report from the Boston Collaborative Drug Surveillance Program

2 references

12 December 2020

https://api.crossref.org/works/10.1007%2FBF02805990

Effects of smoking on haloperidol and reduced haloperidol plasma concentrations and haloperidol clearance

21 January 2018

1 reference

12 December 2020

Latent inhibition and blocking: further consideration of their construct validity as animal models of schizophrenia Commentary on Ellenbroek and Cools "Animal models with construct validity for schizophrenia"

1 reference

12 December 2020

Normalization of auditory physiology by cigarette smoking in schizophrenic patients

1 reference

12 December 2020

Neural substrates of latent inhibition: the switching model

1 reference

12 December 2020

Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine.

1 reference

12 December 2020

Haloperidol potentiation of latent inhibition in rats: evidence for a critical role at conditioning rather than pre-exposure.

1 reference

12 December 2020

Latent inhibition: the effect of nonreinforced pre-exposure to the conditional stimulus.

1 reference

12 December 2020

Nicotine pharmacokinetics and its application to intake from smoking

2 references

12 December 2020

https://api.crossref.org/works/10.1007%2FBF02805990

Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder.

21 January 2018

1 reference

12 December 2020

Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects

1 reference

12 December 2020

Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man.

1 reference

12 December 2020

Signs and symptoms of tobacco withdrawal.

2 references

12 December 2020

https://api.crossref.org/works/10.1007%2FBF02805990

Selective dopamine antagonists reduce nicotine self-administration.

21 January 2018

1 reference

12 December 2020

Correlation of dose-dependent effects of acute amphetamine administration on behavior and local cerebral metabolism in rats.

1 reference

12 December 2020

Schizophrenia and smoking: an epidemiological survey in a state hospital

2 references

12 December 2020

https://api.crossref.org/works/10.1007%2FBF02805990

Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action.

21 January 2018

1 reference

12 December 2020

Facilitation of the expression but not the acquisition of latent inhibition by haloperidol in rats.

1 reference

12 December 2020

Effects of clozapine on latent inhibition in the rat.

1 reference

12 December 2020

The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli.

1 reference

12 December 2020

Sensitivity and tolerance to nicotine in smokers and nonsmokers

1 reference

12 December 2020

Loss of acute nicotine tolerance and severity of cigarette withdrawal

1 reference

12 December 2020

Latent inhibition: a neural network approach.

1 reference

12 December 2020

Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm.

1 reference

12 December 2020

Nicotine intake in smokers increases following a single dose of haloperidol.

1 reference

12 December 2020

Facilitation of latent inhibition by haloperidol in rats.

1 reference

12 December 2020

Effects of smoking on fluphenazine clearance in psychiatric inpatients

1 reference

12 December 2020

Animal models with construct validity for schizophrenia.

1 reference

12 December 2020

Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudate-putamen.

1 reference

12 December 2020

Kinetics, salivary excretion of amphetamine isomers, and effect of urinary pH

2 references

12 December 2020

https://api.crossref.org/works/10.1007%2FBF02805990

Non-smokers show acute tolerance to subcutaneous nicotine

21 January 2018

1 reference

12 December 2020

The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia

1 reference

12 December 2020

Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats

1 reference

12 December 2020

Absorption and metabolism of nicotine from cigarettes

1 reference

12 December 2020

Comparison of tests used to distinguish smokers from nonsmokers.

1 reference

12 December 2020

Haloperidol enhancement of latent inhibition: Relation to therapeutic action?

1 reference

12 December 2020

Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron.

1 reference

12 December 2020

Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics

1 reference

12 December 2020

Disruption of latent inhibition by acute administration of low doses of amphetamine.

1 reference

12 December 2020

Nicotine blocks latent inhibition in rats: evidence for a critical role of increased functional activity of dopamine in the mesolimbic system at conditioning rather than pre-exposure.

1 reference

12 December 2020

Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.

1 reference

12 December 2020

Differential effects of microinjections of d-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus.

1 reference

12 December 2020

Euphoriant effects of nicotine in smokers

1 reference

12 December 2020

Prevalence of smoking among psychiatric outpatients

2 references

12 December 2020

https://api.crossref.org/works/10.1007%2FBF02805990

The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine

21 January 2018

1 reference

12 December 2020

Smoking and schizophrenia

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02805990

0 references

1 reference

4 February 2018